Less Postacute Care for Medicare Advantage Beneficiaries Does Not Mean Worse Health
Research Brief: Shorter Stays in Skilled Nursing Facilities and Less Home Health Didn’t Lead to Worse Outcomes, Pointing to Opportunities for Traditional Medicare
In Their Own Words
The following excerpt is from an op-ed that first appeared in MedPage Today on February 24th, 2024.
If you head to the Florida beaches for spring break, you will notice that the Canadian Maple Leaf is often present among the flags outside hotels and tourist apartments. The benefit to Florida from the annual migration of snowbirds from the North has long been evident, but now something more unusual may be coming from Canada.
On January 5, the FDA approved (with conditions) a request from Gov. Ron DeSantis (R.-Fla.) to import prescription drugs from Canada, making Florida the first state ever given authority to import prescription drugs from another country. The Florida Medicaid program is likely hard at work now devising a plan to source large quantities of drugs from Canada, where unit prices are often small fractions of the U.S. list price.
This unprecedented plan begs many questions: Why is it happening in the first place? Who will benefit from or be harmed by this practice? Could it spread to other U.S. states?
Read the entire op-ed here.

Research Brief: Shorter Stays in Skilled Nursing Facilities and Less Home Health Didn’t Lead to Worse Outcomes, Pointing to Opportunities for Traditional Medicare
How Threatened Reproductive Rights Pushed More Pennsylvanians Toward Sterilization
Abortion Restrictions Can Backfire, Pushing Families to End Pregnancies
They Reduce Coverage, Not Costs, History Shows. Smarter Incentives Would Encourage the Private Sector
Research Brief: Less Than 1% of Clinical Practices Provide 80% of Outpatient Services for Dually Eligible Individuals
New Findings Highlight the Value of 12-Month Eligibility in Reducing Care Gaps and Paperwork Burdens